skip to Main Content
Feeling burned: The first year of legal cannabis has been a complete disaster for investors

Shares of the 10 largest Canadian cannabis producers have been bludgeoned, yielding an average negative return of more than 57%

The legalization of cannabis in Canada was supposed to be a catalyst — the most powerful one yet, investors and analysts alike thought — that would launch companies in the young but potent industry to new heights. Instead, nearly one year later, it has been a nightmare.

Since recreational cannabis became legal on Oct. 17, 2018, the shares of what were then the 10 largest Canadian cannabis producers by market capitalization have been bludgeoned, yielding an average negative return of more than 57 per cent for investors.

Tilray Inc. alone has lost more than $14 billion in market cap, and Aurora Cannabis Inc. has shed $6.8 billion. Six of the Top 10 have lost at least half their value, with scandal-plagued CannTrust Holdings Inc. suffering such resounding losses that it no longer appears in the list. Of the 10, only Cronos Group Inc.’s market cap has grown over the past 12 months, though its share price has declined, like those of all the others on the list.

Prior to legalization, cannabis stocks soared on the promise of massive growth and the tremendous momentum that retail investors brought as they poured into the sector. Now that excitement has been drained, said Richardson GMP portfolio manager Chris Kerlow, and it is unlikely to return. [Read More @ Financial Post]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

Senate Democrats Remove Spending Bill Provision That Blocked D.C. From Legalizing Marijuana Sales

A package of spending bills unveiled by a U.S. Senate committee on Monday evening does not include language that had prohibited D.C. from legalizing the sale of marijuana for the last six years, lifting a significant roadblock to the city’s plans to legalize and license dispensaries to sell the drug for recreational use. Earlier this summer the House of…

Alabama Medical Cannabis Commission: No marijuana licenses before 2022

An Alabama regulatory commission has plenty to do before people can apply for medical cannabis licenses, so it won’t push for a date that might allow sales next year, a commission official said. The Alabama Medical Cannabis Commission had said earlier that it might ask for the date to be moved up. It decided last week not to do…

Panel may scrap South Dakota medical marijuana program for outright legalization

South Dakota’s new medical marijuana law could be scrapped and replaced with what’s being called a “compromise” that would legalize cannabis use for adults. That’s the aim of draft legislation that will be considered Tuesday by a committee that spent the summer and fall studying “adult-use” marijuana policy. “It’s about as close as we’re going to…

Unrivaled Brands’ Frank Kneuttel is Turning the MSO Gameplan On Its Head

Watching Santa Ana, California-based Unrivaled Brands (OTCQX: UNRV) compete in this market reminds me of the movie Memento, where memoryless Guy Pearce literally experiences the action unfold along with the rest of us, even though it’s his story and he’s the only one in it living life essentially in reverse. Similarly, and this may indeed…

More Categories

Back To Top
×Close search
Search